Skip to main content

Queen Mary University of London leads £1.7 million project to revolutionise drug discovery with next-generation organ-chip technology

Queen Mary University of London in collaboration with a consortium of leading pharmaceutical companies, organ-chip technology providers, and regulatory bodies, has secured a £1.7 million research grant from the Engineering and Physical Sciences Research Council (EPSRC) to develop a groundbreaking approach to drug discovery.

Published on:
Back to top